None listed
Conditions
Interventions
Others : Experimental Group : TVAS at 40Hz will be administered twice daily (morning/afternoon) for 8 weeks, with each session lasting 15 minutes.
Control Group : TVAS at 20Hz will be administered twi
Sponsors
AriBio
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals aged 55 to 85 eligible for study participation. 2. Individuals without severe hearing, vision, or speech impairments that could affect the performance and completion of neuropsychological tests or other assessments. 3. Individuals without a history of alcoholism, substance abuse, stroke, or evidence of central nervous system disorders or injuries. 4. Individuals who agree to participate in the study and provide written consent by signing the Informed Consent Form.
Exclusion criteria
Exclusion criteria: 1. Individuals with acute illnesses requiring treatment. 2. Individuals with no history of central nervous system disorders. 3. Individuals who are on long-term medication for mental health conditions (e.g., depression, alcoholism) at the time of the screening test. 4. Individuals diagnosed with disabilities (e.g., blindness in one eye, hearing loss in one ear) at the time of the screening test. 5. Cancer patients who have undergone treatment less than three years prior to the screening test. 6. Individuals who have participated in another study within three months prior to the screening. 7. Individuals who have experienced a stroke within the past 24 months. 8. Individuals deemed unsuitable by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function tests;depression scale assessment; EEG examination; trail-making test;saliva collection | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse even | — |
Countries
Korea, Republic of
Contacts
Public ContactKim Yun-ji
Asian Demensia Foundation
Outcome results
None listed